Page 2 - மருந்து பாலிஸீ சீர்திருத்தம் நாடகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Author Bio Alex began writing for the Fool in early 2020 and follows companies in the healthcare sector. Formerly a researcher in the biotech industry, he leverages his science background in his work as a writer and entrepreneur. His interests include exploring his hometown of Boston, traveling in Latin America, and value investing. Follow @alexcarchidi It s a cliché to say that psychedelic drugs can generate mind-altering experiences. But one biotech is betting that it s possible to use psychedelics to help alter for the better the mental states of people who struggle with disorders like depression and anxiety.  Cybin (OTC:CLXP.F) is developing medicinal psychedelic compounds, and as the name suggests, its lead program is based on psilocybin, the key active chemical in numerous species of magic mushrooms. If you re an adventurous investor looking for a possible 10-bagger opportunity, this is one stock you shouldn t overlook, even if the th

United statesDepartment of justiceDepartment of healthHuman servicesDrug policy reform actஒன்றுபட்டது மாநிலங்களில்துறை ஆஃப் நீதிதுறை ஆஃப் ஆரோக்கியம்மனிதன் சேவைகள்மருந்து பாலிஸீ சீர்திருத்தம் நாடகம்